期刊文献+

急诊内镜在急性上消化道出血中的诊疗价值

下载PDF
导出
摘要 目的对急诊内镜下在急性上消化道出血的诊疗价值进行探讨。方法回顾性分析永州市中心医院2017年1月至2019年1月收治的110例行急诊内镜及择期内镜诊疗急性上消化道出血患者的病例资料,观察组采用常规止血方法及择期内镜(>24 h行胃镜检查),对照组为急诊内镜并采用内镜止血治疗(出血6~24 h行胃镜检查)。比较观察组和对照组的上消化道出血病因检出率、止血有效率、再出血率和手术率及住院时间。结果消化性溃疡、食管胃底静脉曲张是本组急性上消化道出血的主要病因,以消化性溃疡最为常见。对照组的病因检出率(98.2%)显著高于观察组(92.7%)(P<0.05);对照组的止血有效率(96.4%)显著高于观察组(89.1%)(P<0.05),再出血率、手术率和住院时间显著低于观察组(P<0.05)。结论急性上消化道出血患者应用急诊内镜及内镜下治疗,止血效果好,无严重并发症,治疗方法安全可靠,值得在临床中推广应用。
作者 龙丹
出处 《现代医药卫生》 2019年第S01期6-8,共3页 Journal of Modern Medicine & Health
  • 相关文献

参考文献9

二级参考文献103

  • 1Tyson A Hadduck,Justin P McWilliams.Partial splenic artery embolization in cirrhotic patients[J].World Journal of Radiology,2014,6(5):160-168. 被引量:32
  • 2Romaric Loffroy,Louis Estivalet,Violaine Cherblanc,Sylvain Favelier,Pierre Pottecher,Samia Hamza,Anne Minello,Patrick Hillon,Pierre Thouant,Pierre-Henri Lefevre,Denis Krausé,Jean-Pierre Cercueil.Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage[J].World Journal of Gastroenterology,2013,19(37):6131-6143. 被引量:25
  • 3Robert A Enns,Yves M Gagnon,Alan N Barkun,David Armstrong,Jamie C Gregor,Richard N Fedorak,RUGBE Investigators Group.Validation of the Rockall scoring system for outcomes from non-variceal upper gastrointestinal bleeding in a Canadian setting[J].World Journal of Gastroenterology,2006,12(48):7779-7785. 被引量:14
  • 4Olivier Rosmorduc,Chantal Housset.Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease[J]. Semin Liver Dis . 2010 (03)
  • 5Valfrè di Bonzo Lorenzo,Novo Erica,Cannito Stefania,Busletta Chiara,Paternostro Claudia,Povero Davide,Parola Maurizio.Angiogenesis and liver fibrogenesis. Histology and Histopathology . 2009
  • 6Nadia Hamdy,Ebtehal El-Demerdash.New therapeutic aspect for carvedilol: Antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage[J]. Toxicology and Applied Pharmacology . 2012 (3)
  • 7P. Dietrich,L. Moleda,F. Kees,M. Müller,R.H. Straub,C. Hellerbrand,R. Wiest.Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: Impact of exogenous neuropeptide Y[J]. Journal of Hepatology . 2012
  • 8Sang Shin,Minkyu Jung,Hei-Cheul Jeung,Hye Kim,Sun Rha,Jae Roh,Hyun Chung,Joong Ahn.A phase I pharmacokinetic study of TSU-68 (a multiple tyrosine kinase inhibitor of VEGFR-2, FGF and PDFG) in combination with S-1 and oxaliplatin in metastatic colorectal cancer patients previously treated with chemotherapy[J]. Investigational New Drugs . 2012 (4)
  • 9Nuha Ibrahim,Yan Yu,William Walsh,Jia-Lin Yang.Molecular targeted therapies for cancer: Sorafenib mono-therapy andits combination with other therapies (Review)[J]. Oncology Reports . 2012 (5)
  • 10Sandra Brave,Rajesh Odedra,Neil James,Neil Smith,Gayle Marshall,Kerry Acheson,Dawn Baker,Zoe Howard,Lynsay Jackson,Kirsty Ratcliffe,Anna Wainwright,Susan Lovick,D. Hickinson,Robert Wilkinson,Simon Barry,Georgina Speake,Anderson Ryan.Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevantdrug levels in preclinical models of human cancer[J]. International Journal of Oncology . 2011 (1)

共引文献175

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部